JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Inicio・Lista de Acciones・Altimmune Inc

Altimmune Inc

Cerrado

5.11

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

5.02

Máximo

5.25

Métricas clave
By Trading Economics
Ingresos	3.1M -19M
Ventas	5K
Margen de beneficios	-380,280
Empleados	59
EBITDA	4.4M -18M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+199.41% upside

Dividendos
By Dow Jones
Próximas Ganancias	26 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	241M 591M
Apertura anterior	5.11
Cierre anterior	5.11

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

5.365 / 6.0486 Soporte y Resistencia

Altimmune Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ene 2026, 22:31 UTC

Ganancias

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

29 ene 2026, 21:54 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 ene 2026, 21:36 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping

29 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 ene 2026, 23:56 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 ene 2026, 23:53 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 ene 2026, 23:51 UTC

Ganancias

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 ene 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 ene 2026, 23:49 UTC

Charlas de Mercado

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 ene 2026, 23:47 UTC

Charlas de Mercado

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 ene 2026, 23:35 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 ene 2026, 23:32 UTC

Charlas de Mercado

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 ene 2026, 23:32 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

29 ene 2026, 23:15 UTC

Charlas de Mercado

Ganancias

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 ene 2026, 22:27 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 22:27 UTC

Ganancias

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 ene 2026, 22:12 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:55 UTC

Ganancias

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

29 ene 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Health Care Roundup: Market Talk

29 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Auto & Transport Roundup: Market Talk

29 ene 2026, 21:49 UTC

Ganancias

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 ene 2026, 21:46 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 ene 2026, 21:36 UTC

Ganancias

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 21:30 UTC

Ganancias

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 ene 2026, 21:30 UTC

Ganancias

Apple 1Q Mac Rev $8.39B >AAPL

Comparación entre iguales

Cambio de precio

Altimmune Inc previsión

Precio Objetivo

By TipRanks

199.41% repunte

Estimación a 12 Meses

Media 15.33 USD 199.41%

Máximo 20 USD

Mínimo 12 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Altimmune Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Altimmune Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

5.365 / 6.0486Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.